As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged carries a market capitalization of 247.54B, placing it among publicly traded companies globally. Its enterprise value stands at 286.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 247.54B |
| Enterprise Value | 286.60B |
Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's next confirmed earnings release is scheduled for January 27, 2027.
| Earnings Date | 1/27/2027 |
As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has 14.19B shares outstanding.
| Shares Outstanding | 14.19B |
These figures are as of September 30, 2026.
| PB Ratio | 3.41 |
| P/TBV Ratio | -144.14 |
As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.45 |
| Quick Ratio | 1.00 |
| Debt / Equity | 60.36 |
These figures cover the twelve months ended September 30, 2026.
| Employee Count | 115,000.00 |
Over the twelve months ended September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged recorded 1.80B in income tax expense.
| Income Tax | 1.80B |
These figures are as of the close on November 12, 2026.
| 50-Day Moving Average | 18.46 |
As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged holds 6.12B in cash and equivalents against 44.33B in total debt, resulting in a net debt position of 38.57B. Total book value stands at 72.60B, with working capital of 10.45B providing operational flexibility.
| Cash & Cash Equivalents | 6.12B |
| Total Debt | 44.33B |
| Net Debt | 38.57B |
| Equity (Book Value) | 72.60B |
| Book Value Per Share | 5.12 |
| Working Capital | 10.45B |
These figures cover the twelve months ended September 30, 2026.
| Capital Expenditures | -2.28B |
Over the twelve months ended September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged paid dividends of 0.32 per share.
| Dividend Per Share | 0.32 |